MUTABILIS SA has a total of 20 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BLACK JAMES FOUNDATION, TRIO MEDICINES LTD and NABRIVA THERAPEUTICS FORSCHUNG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | China | 2 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Medical preparations | |
#7 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Escaich Sonia | 16 |
#2 | Moreau Francois | 10 |
#3 | Gerusz Vincent | 9 |
#4 | Denis Alexis | 9 |
#5 | Bonvin Yannick | 5 |
#6 | Desroy Nicolas | 4 |
#7 | Oxoby Mayalen | 3 |
#8 | Vincent Stephane | 2 |
#9 | Oliveira Chrystelle | 1 |
#10 | Alexis Denis | 1 |
Publication | Filing date | Title |
---|---|---|
EP2104671A2 | Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors | |
AU2007285462A1 | Identification of genes implicated in the virulence of streptococcus | |
EP1972629A1 | New imidazolo-heteroaryl derivatives with antibacterial properties | |
EP1845087A1 | Hydroxyphenyl derivatives and biological applications thereof | |
EP1669365A1 | Method for preparing enzymatic substrate analogs as inhibitors of bacterial heptosyl-transferases | |
EP1580195A1 | Compositions of polypeptides specific to pathogenic ExPEC E. coli strains and their use as vaccines and in immunotherapy | |
CA2478277A1 | Expec-specific proteins, genes encoding them and uses thereof |